BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting

2d ago

BTAI

PremiumCompany Announcements

Bioxcel Therapeutics Advances SERENITY Trial and Strategy

4d ago

BTAI

PremiumThe Fly

BioXcel announces plan for evaluating BXCL501 in at-home setting

4d ago

BTAI

PremiumThe Fly

BioXcel Therapeutics price target lowered to $10 from $11 at H.C. Wainwright

11d ago

BTAI

PremiumCompany Announcements

Bioxcel Therapeutics Advances Alzheimer’s Agitation Treatment Trial

16d ago

BTAI

PremiumThe Fly

BioXcel Therapeutics announces TRANQUILITY In-Care Phase 3 trial plan

16d ago

BTAI

PremiumPress Releases

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia

16d ago

BTAI

More BTAI News >

BTAI News on the Web

2024-04-13

AI Surge Has Ended: All 7 AI Stock Categories Declined This Week

TalkMarkets

Neutral

2024-04-10

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia

Yahoo Finance

Bullish

2024-03-27

Bioxcel Therapeutics: Navigating Financial Pressures and Clinical Trials – A Hold Rating Analysis

TipRanks News

Neutral

2024-03-25

Is BioXcel Therapeutics Inc (BTAI) a Bad Choice in Biotechnology Monday?

Investors Observer

Neutral

2024-03-25

BioXcel Therapeutics Announces $25 Million Registered Direct Offering

Yahoo Finance

Neutral

2024-03-24

BioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint

Yahoo Finance

Neutral

2024-03-24

Bioxcel Therapeutics Faces Market Estimation Risks Amidst Adoption and Access Challenges

TipRanks News

Neutral

2024-03-23

Six Of Seven AI Stock Categories Increased This Week

TalkMarkets

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BTAI’s Media Buzz Sentiment?

Currently, no data Available

What is BTAI’s weekly average amount of articles?

Currently, no data Available

What is BTAI’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing